Obstruktif Uyku Apne Sendromlu Hastalarda Fibrinojen Düzeylerinin Değerlendirilmesi

Yıl 2019, , 305 - 310, 01.12.2019

Ezgi Demirdöğen , Ahmet Ursavaş , Mehmet Karadağ , Funda Coşkun , Dane Ediger Esra Uzaslan Ercüment Ege Oktay Gözü

https://doi.org/10.32708/uutfd.645039

Öz

Obstrüktif uyku apne sendromu (OUAS) hastalarında vasküler hastalık riski artmıştır. Bu hastalarda kardiyovasküler hastalık gelişimine ait kesin mekanizma bilinmemektedir. Fibrinojen normal plazmanın ana bileşenidir. Akut faz reaktanı olan fibrinojen düzeyleri inflamatuar yanıtın bir parçası olarak yükselmektedir. Fibrinojenin koroner arter hastalığı ve inme için bağımsız risk faktörü olduğu gösterilmiştir. Çalışmamızda yeni orta/ağır OUAS tanısı almış hastalarda ve non-apneik olgularda plazma fibrinojen düzeylerini karşılaştırmayı ve polisomnografi (PSG) parametreleri ile ilişkisini değerlendirmeyi amaçladık. Tüm gece PSG sonrası yeni tanı almış 50 orta ve ağır OUAS olgusu ile 33 nonapneik kontrol olgu çalışmaya dahil edilmiştir. uyku çalışmasının ardından sabah 8.00-9.00 saatleri arasında kan örnekleri alınarak plazma fibrinojen düzeyleri Clauss metodu ile ölçülmüştür. Her iki grup arasında yaş, cinsiyet, sigara alışkanlığı açısından fark saptanmadı. Plazma fibrinojen düzeyleri OUAS grubunda (4.2 ± 0.14 g/L) kontrol grubuna göre anlamlı derecede yüksek bulundu (p<0.028). Plazma fibrinojen düzeyleri; Epworth uykululuk skalası (ESS) skoru (r=0.301, p=0.006), yaş (r=0.327, p=0.003), beden kitle indeksi (BKİ) (r=0.388, p<0.001), ortalama oksijen desaturasyonu (r=0.258, p=0.019), oksijen desaturasyon indeksi (r=0.281, p=0.010), oksijen satürasyonunun % 90’ın altında kalma süresi (r=0.248, p=0.024) ve arousal indeksi (r=0.220, p=0.046) ile pozitif korele idi. Plazma fibrinojen düzeyleri ile uykudaki oksijen saturasyonu arasında (r= -0.254, p=0.029) negatif korelasyon mevcuttu. Çoklu doğrusal regresyon analiz ile EUS skoru ve BKİ’nin, AHİ’den bağımsız olarak, fibrinojen düzeyleri ile ilişkili değişkenler olduğu saptanmıştır. Sonuçta plazma fibrinojen düzeyleri ile ESS ve BKİ’nin ilişkili olduğu bulunmuştur. Fibrinojen düzeyleri ve nokturnal desaturasyon arasındaki ilişki, hipoksi inflamasyon ilişkisini desteklemektedir. Yüksek fibrinojen düzeylerinin OUAS’lı hastalarda vasküler hastalık gelişimi için önemli bir faktör olabileceği sonucuna varılmıştır.

Anahtar Kelimeler

Obstrüktif uyku apne sendromu (OUAS), fibrinojen, Epworth uykululuk skalası (ESS), hipoksi, vasküler hastalık.

Evaluation of Fibrinogen Levels in Patients with Obstructive Sleep Apnea

Öz

Risk of vascular disorders is increased at obstructive sleep apnea syndrome (OSAS) patients. The exact mechanism of development of vascular disease in patients with OSAS remains to be unknown. Fibrinogen is a major constituent of normal plasma. Fibrinogen is an acute phase reactant, with increasing levels as part of the of the acute inflammatory response. Fibrinogen has been shown to be an independent risk factor for coroner heart disease and stroke. Our aim was to compare plasma fibrinogen levels between OSAS and control groups, and relationship with polysomnograhy (PSG) parameters. Fifty patients with newly diagnosed moderate and severe OSAS and 33 non-apneic control subjects were enrolled in this study. Full-night PSG was performed in all patients. Blood samples were drawn at 8:00-9:00 am after the sleep study. Fibrinogen levels were analyzed with Clauss method. There were no significant differences in age, gender, smoking habit between the two groups. Plasma fibrinogen levels in the OSAS group (4.2 ± 0.14 g/L) were significantly higher than that in the control group (p<0.028). Plasma fibrinogen levels were positively correlated with Epworth sleepiness scale (ESS) (r=0.301, p=0.006), age (r=0.327, p=0.003), body mass index (BMI) (r=0.388, p<0.001), average oxygen desaturation (r=0.258, p=0.019), oxygen desaturation index (r=0.281, p=0.010), length of time spent with an oxygen saturation <90% (r=0.248, p=0.024) and arousal index (r=0.220, p=0.046). Plasma fibrinogen levels were negatively correlated with average oxygen saturation during sleep (r= -0.254, p=0.029). Multipl linear regression analyses showed that high ESS and BMI were related with elevated plasma fibrinogen levels, independent of apne hipopne index. In conclusion we suggest that plasma fibrinogen levels correlate with BMI and ESS. The association between plasma fibrinogen levels and nocturnal desaturation supports the linkage between hypoxia and inflamation. We conclude that fibrinogen may be an important factor for development of vascular disease in patients with OSAS.

Anahtar Kelimeler

Obstructive sleep apnea syndrome (OSAS), fibrinogen, Epworth sleepiness scale (ESS), hypoxia, vasculer disease

Kaynakça

• 1. Börgel J, Sanner BM, Bittlinsky A, et al. Obstructive sleep apnoea and its therapy influence high-density lipoprotein cholesterol serum levels. Eur Respir J 2006;27:121-7.
• 2. Can M, Açıkgöz S, Mungan G, et al. Serum cardiovascular risk factors in obstructive sleep apnea. Chest 2006;129:233-7.
• 3. Zouaoui Boudjeltia K, Van Meerhaeghe A, Doumit S, et al. Sleep apnoea-hypopnoea index is an independent predictor of high-sensitivity C-reactive protein elevation. Respiration 2006;73:243-6.
• 4. Dyugovskaya L, Lavie P, Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 2002;165:934–9.
• 5. Lavie L, Vishnevsky A, Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 2004;27:123–8.
• 6. Reichmuth KJ, Austin D, Skatrud JB, Young T. Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005;172:1590-5.
• 7. Harsch IA, Schahin SP, Radespiel-Tröger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156–62.
• 8. Meade TW. Fibrinogen measurement to assess the risk of arterial thrombosis in individual patients: yes. J Thromb Haemost 2005;3:632–4.
• 9. Rudnicka AR, Mt-Isa S, Meade TW. Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial. Journal of Thrombosis and Haemostasis 2006,4:2405–10.
• 10. Danes J, Lewington S, Thompson SG, et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA 2005;294:1799-809.
• 11. Meade TW, North WR, Chakrabarti R, et al. Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1980;1:1050–4.
• 12. Izci B, Ardic S, Firat H, Sahin A, Altinors M, Karacan I. Reliability and validity studies of the Turkish version of the Epworth Sleepiness Scale. Sleep Breath. 2008 May;12(2):161-8.
• 13. Berry RB, Budhiraja R, Gottlieb DJ, et al.; American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012 Oct 15;8(5):597-619. doi: 10.5664/jcsm.2172.
• 14. Shahar E, Whitney CW, Redline S, et al. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 2001;163:19–25.
• 15. Somers VK, White DP, Amin R, et al. Sleep apnea and cardiovascular disease: an American Heart Association/american College Of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 2008;118:1080-111.
• 16. Davies CW, Crosby JH, Mullins RL, et al. Case-control study of 24 hour ambulatory blood pressure in patients with obstructive sleep apnoea and normal matched control subjects. Thorax 2000;55:736–40.
• 17. Baguet JP, Hammer L, Levy P, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens 2005;23:521–7.
• 18. Fung JW, Li TS, Choy DK, et al. Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. Chest 2002;121:422–9.
• 19. Drager LF, Bortolotto LA, Lorenzi MC, et al. Early signs of atherosklerosis in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172:613-8.
• 20. McArdle N, Riha RL, Vennelle M, et al. Sleep-disordered breathing as a risk factor for cerebrovascular disease: a case-control study in patients with transient ischemic attacks. Stroke 2003;34:2916-21.
• 21. Dziewas R, Ritter M, Kruger L, et al. C-reactive protein and fibrinogen in acute stroke patients with and without sleep apnea. Cerebrovasc Dis 2007;24:412-7.
• 22. Peled N, Kassirer M, Kramer MR, et al. Increased erythrocyte adhesiveness and aggregation in obstructive sleep apnea syndrome. Thromb Res 2008;121:631-6.
• 23. Sanders MH, Givelber R. Sleep disordered breathing may not be an independent risk factor for diabetes, but diabetes may contribute to the occurrence of periodic breathing in sleep. Sleep Med 2003;4:349-50.
• 24. Sharma SK, Kumpawat S, Goel A, et al. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007;8:12-7.
• 25. Sharma SK, Mishra HK, Sharma H, et al. Obesity, and not obstructive sleep apnea, is responsible for increased serum hs-CRP levels in patients with sleep-disordered breathing in Delhi. Sleep Med 2008;9:149-56.
• 26. Saraç F, Özgen GA, YIlmaz C, Tüzün M. Cardiovascular risk factors in obese women and their first-degree relatives. Anadolu Kardiyol Derg 2007;7: 371-7.
• 27. Basoglu OK, Sarac F, Sarac S, Uluer H, Yilmaz C. Metabolic syndrome, insulin resistance, fibrinogen, homocysteine, leptin, and C-reactive protein in obese patients with obstructive sleep apnea syndrome. Ann Thorac Med. 2011 Jul;6(3):120-5. doi: 10.4103/1817-1737.82440.
• 28. Bixler EO, Vgontzas AN, Lin HM, et al. Excessive daytime sleepiness in a general population sample: the role of sleep apnea, age, obesity, diabetes, and depression. J Clin Endocrinol Metab 2005;90:4510–5.
• 29. Reishtein JL, Pack AI, Maislin G, et al. Sleepiness and relationships in obstructive sleep apnea. Issue Mental Health Nurs 2006;27:319–30.
• 30. Kapur VK, Baldwin CM, Resnick HE, et al. Sleepiness in patients with moderate to severe sleep-disordered breathing. Sleep 2005;28:472–7.
• 31. Shamsuzzaman ASM, Somers VK. Fibrinogen, stroke and obstructive sleep apnea. Am J Respir Crit Care Med 2000;162:2018–20.
• 32. Rosito GBA, Tofler GH. Hemostatic factors as triggers of cardiovascular events. Cardiol Clin 1996;14:239–50.
• 33. Koenig W. Hemostatic risk factors for cardiovascular diseases. Eur Heart J 1998;19:39-43.
• 34. Dimsdale JE, Coy T, Ziegler MG et al. The effect of sleep apnea on plasma and urinary catecholamines. Sleep 1995;18:377–81.
• 35. Bokinsky G, Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: a preliminary investigation. Chest 1995;108:625–30.
• 36. Wessendorf TE, Thilmann AF, Wang YM, et al. Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 2000;162:2039–42.
• 37. Sekosan M, Zakkar M, Wenig BL, Olopade CO, Rubinstein I. Inflammation in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope 1996;106:1018–20.
• 38. Nobili L, Schiavi G, Bozano E, et al. Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 2000;22:21–27.
• 39. Chin K, Ohi M, Kita H, et al. Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 1996;153:1972–6.
• 40. Reinhart WH, Oswald J, Walter R, Kuhn M. Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clin Hemorheol Microcirc 2002;27:201-7.
• 41. Kaditis AG, Alexopoulos EI, Kalampouka E, et al. Morning levels of fibrinogen in children with sleep-disordered breathing. Eur Respir J 2004;24:790-7.
• 42. Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogenin otherwise healthy patients. Sleep Breath. 2014 Dec;18(4):761-6. doi: 10.1007/s11325-014-0938-4.